Miguel ESCOBAR, MD
The University of Texas Health Science Center, Houston · Memorial Hermann Texas Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Miguel ESCOBAR, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:13 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT05695391 · Safety and Efficacy of FVIIa to Prevent Excessive Bleeding in Hemophilia Patients With Inhibitors Undergoing Major SurgeryLaboratoire français de Fractionnement et de Biotechnologies · terminated · Hemophilia · principal investigator
- Ph3NCT02548143 · LR769 in Congenital Hemophilia Patients With Inhibitors Undergoing Elective Surgery or Invasive ProceduresLaboratoire français de Fractionnement et de Biotechnologies · completed · Hemophilia · principal investigator
- N/ANCT00178607 · Covalent Tolerance Induction to Factor VIII-Prediction of Inhibitors in HemophiliaThe University of Texas Health Science Center, Houston · completed · Hemophilia A · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:13 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.